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Objective. To compare Visual Analogue Scale (VAS) scores with overall postoperative pain medication requirements including
cumulative dose and patterns of medication utilization and to determine whether VAS scores predict pain medication utilization.
Methods. VAS scores and pain medication data were collected from participants in a randomized trial of the utility of phenazo-
pyridine for improved pain control following gynecologic surgery. Results. The mean age of the 219 participants was 54 (range19
to 94). We did not detect any association between VAS and pain medication utilization for patient-controlled anesthesia (PCA)
or RN administered (intravenous or oral) medications. We also did not detect any association between the number of VAS scores
recorded and mean pain scores. Conclusion. Postoperative VAS scores do not predict pain medication use in catheterized women
inpatients following gynecologic surgery. Increased pain severity, as reﬂected by higher VAS scores, is not associated with an in-
crease in pain assessment. Our ﬁndings suggest that VAS scores are of limited utility for optimal pain control. Alternative or com-
plimentary methods may improve pain management.
1.Introduction
Optimal postoperative pain control has been identiﬁed as
a potentially important modiﬁer of both short- and long-
termsurgicaloutcomes[1].Uncontrolledpostoperativepain
has been linked to loss of respiratory mechanics [2, 3]a n d
cardiac morbidity through activation of the sympathetic
nervous system, coagulation cascade, and surgical stress
response [4, 5]. Suppression of this stress response via pain
control has been suggested to decrease risk of post operative
ileus through reduction of the inﬂammatory response to
surgery [6, 7]. Post operative pain may be a major determi-
nantofsurgicalwoundinfection,asshownwithdatabyAkca
et al. [8] revealing increased subcutaneous oxygen partial
pressures and perfusion to tissue in patients with better pain
control than patients with inadequate pain control.
Quality of life in the post operative period is dependent
on adequate pain relief. Eﬀective pain control in the early
post operative period may also lead to clinically important
beneﬁts for long-term recovery, including less chronic pain
[9, 10]. The association between the intensity of acute post
operative pain and later development of chronic pain has
been demonstrated after inguinal hernia repair [11], breast
surgery [12], and thoracotomy [13].
Patient satisfaction and perception of quality of care has
been shown to be linked to provider eﬀorts to optimize
pain control. A 2008 survey conducted by the Joint Commis-
sion on Accreditation of Healthcare Organizations (JCAHO)
reported a clear relationship between responses to patient’s
overall satisfaction with pain management and their per-
ceptions of pain assessment frequency, response time, and
concern demonstrated by staﬀ [14]. This study also demon-
strated that patients’ actual pain severity score did not relate
to perceived overall satisfaction with pain management.
Visual Analogue Scales (VAS) have been utilized in mul-
tiple clinical and experimental settings to measure pain [15]
a n dh a v eb e e nd e m o n s t r a t e dt ob er e l i a b l e[ 16–18], gener-
alizable [19, 20], and internally consistent measures of pain
sensation and intensity [16, 19]a sw e l la ss e n s i t i v em e a s u r e s
ofeﬀectsofanalgesictreatments[21–24].ThoughVASscores
areusedinavarietyofsituationstocomparepaintreatments,
there is no report in the literature comparing mean VAS
scoreandpainmedication utilization ormeanVAS scoreand
frequency of documented post operative pain assessment.2 Pain Research and Treatment
Table 1: Demographic data and surgery type (N = 219).
Age (mean) 54 years (SD 14)
Race
Caucasian 174 (80%)
African american 32 (15%)
Hispanic 3 (1%)
Other (asian, native american) 10 (4%)
Surgery type
Abdominal 182 (83%)
Vaginal 43 (20%)
Laparoscopic 77 (35%)
∗Participants could be categorized as both abdominal and laparoscopic,
depending on their procedure.
As a planned secondary analysis of a registered random-
ized controlled trial, we compared mean VAS and post oper-
ative utilization to determine whether VAS scores predict
pain medication utilization. In addition, we explored the
relationship of pain severity, as reﬂected by the VAS score,
and the frequency of pain assessment. We hypothesized that
patients with higher mean VAS scores would have more
frequent VAS assessments and higher pain medication util-
ization.
2.MaterialsandMethods
Data for this planned secondary analysis was collected as
part of the Catheter Analgesia (CATH) study, an IRB
approved, randomized trial, registered at clinicaltrial.gov
(NCT00771173). The primary study was designed to deter-
mine whether phenazopyridine improved pain in catheter-
ized inpatients recovering from gynecologic surgery. Two
hundred and nineteen women were assigned 1:1 to placebo
or phenazopyridine HCl between September 2008 and Sep-
tember 2009. Group assignment was masked by instillation
of orange dye in the Foley bag of both groups.
Eligible candidates were adult women undergoing gyne-
cologic surgery who required an indwelling catheter for a
minimum of 12 postoperative hours and who could tolerate
oral pain medications within 12 post operative hours. Cri-
teria for exclusion included hypersensitivity to phenozopy-
ridine, hepatic failure or other known contraindications
to phenazopyridine, suprapubic catheterization, inability to
take oral medication within 12 hours after surgery, and
pregnancy. Patients with intraoperative urologic injury were
excluded.
Randomized participants received either 200mg phen-
azopyridine or placebo oral capsule every eight hours while
Foley catheter in place or for 24 hours post operatively,
whichever came ﬁrst. Group assignments were known only
to the research pharmacist who randomized subjects imme-
diately following completion of surgery. Randomization was
performed utilizing sequentially numbered opaque envel-
opes generated by a randomized block permutation. Surgical
pain was clinically treated without standardization.
TheprimaryoutcomewasmeanVASmeasurementsdur-
ing the postoperative period according to standard clinical
Table 2: VAS score assessment frequency.
Number VAS scores recorded per subject Frequency
0 14% (31)
1 17% (39)
2 18% (40)
3 19% (41)
4 9% (20)
5 10% (22)
63 % ( 6 )
>6 10% (20)
order sets. The clinical VAS scores were obtained during
clinical care by nurses, residents, and anesthesiologists. The
investigators later abstracted the data from the electronic
medical record (EMR). Randomized participants who did
not have at least one VAS score recorded were not included
in the analysis.
Results from the primary project have been reported sep-
arately[25].Datafrequenciesandregressionwereperformed
with SPSS-pc, Version 16.0 [26]. We combined the two
groupsforthestatisticscomparingbothVASandpostopera-
tivepainmedicationutilizationaswellasVASfrequencywith
mean VAS scores.
3. Results and Discussion
The demographic data and surgery type for the 219 par-
ticipants are presented in Table 1. Most participants were
Caucasian (80%); the mean age was 55 years old. Surgical
groups included: abdominal procedures (83%), laparoscopic
procedures(35%),andvaginalsurgery(20%).Patientscould
be assigned to both a laparoscopic group as well as the ab-
dominal group.
The mean length of study participation was eighteen
hours during which 187 patients (86%) had at least one VAS
recorded. Table 2 presents the VAS frequency data for the
total of 647 VAS assessments available for analysis.
The mean VAS score was 2. Most VAS scores (86%) were
<2. Approximately 1 in 5 (22%) participants reported that
their highest VAS score was zero. We did not detect clinical
or statistical diﬀerences in the mean VAS scores for the study
group compared to the placebo group (P = 0.820) [25].
Figure 1 presents the distribution of each VAS score as-
sessment. There was no association when comparing time
and VAS score.
VAS score frequency, meaning the number of scores re-
corded, and mean VAS scores are compared in Figure 2.P a i n
assessment frequency was not predictive of mean VAS score
(r2 .006).
Mean VAS score and pain medication utilization are pre-
sented in Figures 3, 4, 5,a n d6.W ed on o ts e em e a nV A S
scores as predictive of morphine PCA use (r2 0.035), IV non-
narcotic use (r2 0.01), or oral narcotic pain medication use
(r2 < .001 for 5mg, r2 0.012 for 10mg). The number of
participants using other oral narcotics was insuﬃcient for
analysis.Pain Research and Treatment 3
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Figure 1: VAS score distribution over time: (note: time intervals
were not standardized). Early (VAS1) to later (VAS 10) assessment:
VAS 1 represents the earliest chronological assessment after surgery,
with VAS 2 and forward representing subsequent assessments later
in the postoperative period.
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Figure 2: Number of VAS scores recorded and mean VAS.
4. Conclusions
We found that the impact of post operative mean VAS scores
was extremely limited, predicting neither pain medication
utilization nor frequency of pain assessment in our sample
of post operative gynecologic surgery patients. Each patient’s
interpretation of the VAS score is highly individualistic given
diﬀerence in pain tolerance and perception. Likewise, deci-
siontoacceptpainmedicationaremultidimensionalandnot
based on a unidimensional determination of pain severity.
Within the context of a well-designed and controlled ran-
domized clinical trial, the utilization of multiple modalities
more closely resembles the individualized pain medication
strategy as currently advocated. The ﬁndings of this study
can be generalized to similar populations of gynecologic
surgical patients, given distribution of procedure type and
demographics.
DespitethepurportedutilityofVASscores,wefoundthat
the scores did not appear to guide clinical care or optimize
pain management. We were surprised that only 49% of our
participants had 2 or less VAS scores recorded over the
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Figure 3: Mean VAS score and morphine PCA utilization (mg).
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Figure 4: Mean VAS score and frequency ketorolac utilization
(30mg).
average study time of 18 hours. This may be due to a failure
of clinical staﬀ to prioritize VAS scores collection. Although
we were surprised by this ﬁnding given the emphasis that
JCAHO places on the VAS score as the “ﬁfth vital sign,” it
was not necessarily representative of poor pain control, as
evidenced by the low VAS scores.
VAS utility may be limited by perceptions that it is more
diﬃcult and time consuming to assess in comparison to a
simple numerical rating scale of 1 to 5 or 1 to 10 [15]. Our
ﬁndings are particularly interesting in light of the JCAHO
study, which showed that patients’ actual pain intensity did
not relate to perceived overall satisfaction but that patients’
overall satisfaction with pain management was predicted
by their perceptions of pain assessment frequency, response
time, and concern demonstrated by staﬀ [14].
Pain medication utilization did not increase with in-
creased VAS scores. This supports the idea of pain sensation
andcontrolasanindividualizedexperience.Neitherself-nor
RN-administered pain medication utilization was associated
with VAS scores. This suggests that patients with higher
scores did not use more medication, perhaps secondary to
increased pain tolerance than those with lower scores who
used the same amount of medication. We did not collect
medication administration times, which if linked to VAS4 Pain Research and Treatment
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Figure 5: Mean VAS score and frequency Hydrocodone + Acetami-
nophen 5mg administered (0=never administered, 10 = 5 admin-
istrations recorded during study participation).
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Figure 6: Mean VAS score and frequency Hydrocodone + Acetami-
nophen 10mg administered (0=never administered, 10 = 5 admi-
nistrations recorded during study participation).
time could have provided more insight to when and why pa-
tients with consistently low scores were receiving pain med-
ication, and conversely those with higher scores were not
receiving higher medication doses.
Our ﬁndings provide further support to the literature
indicating large variability between individuals in response
tonoxioussurgicalstimuli[27,28].Wesuggestthatourﬁnd-
ings be used to expand assessments of pain in the post
operative period to include an understanding of a patient’s
pain threshold, beliefs about pain relief, decisions to utilize
pain medication and response to pain medications. Ideally,
customized regimens could be implemented to optimize
postoperative pain treatment while minimizing side eﬀects
of medication [29].
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